SDZ-MKS-492 | m-entrepreneurship.com

Product Name :
SDZ-MKS-492

Search keywords :
SDZ-MKS 492

drugId :
null

Target Vo:
3′,5′-cyclic phosphodiesterase

Target Vo Short Name :
cGMP-PDE

Moa_Name:
3′,5′-cyclic phosphodiesterase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Asthma

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
p16 Antibody
TRITC-conjugated AffiniPure Goat Anti-Mouse IgG H&L
CYP7A1 Antibody: CYP7A1 Antibody is an unconjugated, approximately 55 kDa, rabbit-derived, anti-CYP7A1 polyclonal antibody. CYP7A1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF, expriments in human, mouse background without labeling.

Author: Betaine hydrochloride

Related Posts